It has been shown that glioma progenitor cells enhance mTOR signaling in microglia but not in BMDMs via the PI3K (phosphatidylinositol 3 kinase)/Akt (Protein Kinase B) axis. The gene discussed is MTOR; the disease is central nervous system cancer.